| DB ID | MyCo_2938 |
| Title | Prospective Evaluation of a New Aspergillus IgG Enzyme Immunoassay Kit for Diagnosis of Chronic and Allergic Pulmonary Aspergillosis |
| Year | 2016 |
| PMID | 26888904 |
| Fungal Diseases involved | Chronic and allergic pulmonary aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Anti-Aspergillus IgG |
| Biomarker Full Name | Anti-Aspergillus IgG |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | France |
| Cohort | This prospective study was conducted in the five French university hospitals of Grenoble, Rennes, Lyon, Dijon, and Besançon. Immunocompetent patients with suspected noninvasive aspergillosis were included between January 2013 and April 2015. Here included 352 patients in total. They had a median age of 58.9 years (quartile 1, 47.0 years; quartile 3, 71.5 years), 5% were minors (age, 18 years), and 55% were male. |
| Cohort No. | 352 |
| Age Group | 58.9 |
| P Value | None |
| Sensitivity | 0.917 |
| Specificity | 0.913 |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | FDA Approved -Platelia Aspergillus Ag ELISA |
| ELISA kits | ELISA Kit- Platelia Aspergillus; Bio‐Rad laboratories, Marnes‐la- Coquette, France, ELISA Kit A. fumigatus IgG assay (Bordier Affinity Products) |
| Assay Data | A. fumigatus IgG assay (Virion Serion) |
| Validation Techniques used | FDA Approved -Platelia Aspergillus Ag ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
